The most accurate measure of whether or not gender affirming care harms or hurts transgender youth is to look at actual research studies that have been conducted. All of the research studies have shown that gender affirming care is associated with decreases in depression and dysphoria. This information has been shared on these boards numerous times, but you choose to ignore the results of actual research studies and instead double-down on your personal opinion on a topic which does not affect you. Pinkle's take on this was spot on.
Here are links to a few real research studies with relevant quotations. I could provide plenty more.
“In this prospective cohort of 104 TNB youths aged 13 to 20 years, receipt of gender-affirming care, including puberty blockers and gender-affirming hormones, was associated with 60% lower odds of moderate or severe depression and 73% lower odds of suicidality over a 12-month follow-up.”
"In this secondary analysis of the 2015 US Transgender Survey (n = 27 715), TGD people with a history of gender-affirming surgery had significantly lower odds of past-month psychological distress, past-year tobacco smoking, and past-year suicidal ideation compared with TGD people with no history of gender-affirming surgery."
“Key advances in the care of TGD youth include the recognition that being transgender or gender diverse is not rare, and that being TGD is no longer considered a mental illness, but rather represents an example of human diversity (6). Numerous studies, primarily of short- and medium-term duration (up to 6 years), demonstrate the clearly beneficial—even lifesaving—mental health impact of gender-affirming medical care in TGD youth. Long-term safety and efficacy studies are needed to optimize medical care for TGD youth.”
“After gender reassignment, in young adulthood, the GD was alleviated and psychological functioning had steadily improved. Wellbeing was similar to or better than same-age young adults from the general population. Improvements in psychological functioning were positively correlated with postsurgical subjective well-being.”
“A 2020 survey of 11,914 transgender or nonbinary youth, aged 13–24 years, of whom 14% were receiving GAHT, demonstrated that such treatment was associated with lower odds of recent depression and serious consideration of suicide compared to those who wanted such care but did not receive it.”